Hanmi Science Q1 2026: Net profit +73% YoY, Operating profit +24% YoY
- Consolidated revenue: KRW 353.7B (+6.5% YoY, +2.8% QoQ)
- Operating profit: KRW 33.6B (+24% YoY, -11.1% QoQ)
- Pre-tax profit: KRW 45.3B (+70% YoY, +22% QoQ)
- Net income: KRW 42.3B (+73% YoY, +27.9% QoQ)
- Controlling interest net income: KRW 42.7B (+70.4% YoY, +32.4% QoQ)
- No shareholder return items (no share buyback, cancellation, or dividends disclosed)
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
- Company: Hanmi Science (008930)
- Submission: Hanmi Science Co.,Ltd
- Receipt: 04-30-2026
- Under KRX KOSPI Market Division